SPONSOR CONTENT BY GENENTECH

New opportunities for breast cancer immunotherapy

Immunotherapy is the story of the decade in cancer therapy. We’ve seen exciting advances across several tumor types, with significant improvement in long-term outcomes. Yet some cancers, including breast cancer, have shown little response to this new class of medicines. Learn more about potential strategies to address non-immunogenic tumors, like breast cancer, from Genentech’s Immuno-Oncology Global Development Leader Dr. Amreen Husain.

https://www.statnews.com/sponsor/2018/10/03/new-breast-cancer-immunotherapy-opportunities-genentech/?utm_source=Product+test&utm_campaign=ae03b813ca-EMAIL_CAMPAIGN_2018_06_22_02_21_COPY_04&utm_medium=email&utm_term=0_814590368b-ae03b813ca-&utm_source=STAT+Newsletters&utm_campaign=0e0e824c63-MR_COPY_03&utm_medium=email&utm_term=0_8cab1d7961-0e0e824c63-149692869